Pharmadrug Inc. LMLLF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score

7/100

0/4 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

Income Statement Balance Sheet Cash Flow Statement

Annual Quarterly

Pharmadrug Inc. (LMLLF) reported total assets of $711.8K and total liabilities of $1.96M for fiscal year 2024, resulting in total equity of $-1.24M.

The company held $75.04K in cash and short-term investments. Total debt stood at $1.35M, with net debt of $1.27M. The Debt-to-Equity (D/E) ratio was -1.08 (conservative).

Current ratio is 0.08, which may signal tight short-term liquidity.

Criteria supported by this page:

HEALTH (0/100, Fail) — the balance sheet shows elevated risk in debt or liquidity metrics
MOAT (11/100) — Total assets $711.8K and equity $-1.24M support the company's competitive scale

Overall SharesGrow Score: 6/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score

7/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

0/100

→ Income

✗

HEALTH

0/100

Debt-to-Equity & liquidity

Proven by this page

✗

MOAT

11/100

→ Income

✗

GROWTH

15/100

→ Income

—

INCOME

N/A

No coverage

Pharmadrug Inc. Balance Sheet History

Metric	FY2024	FY2023	FY2022	FY2021
Total Assets	$711.8K	$1.2M	$12.11M	$19.52M
Total Liabilities	$1.96M	$2.66M	$3.28M	$2.66M
Total Debt	$1.35M	$1.77M	$1.42M	$866.37K
Cash & Investments	$75.04K	$423.06K	$329.24K	$1.3M
Total Stockholders Equity	$-1.4M	$-1.7M	$8.84M	$16.87M